logo-loader
viewSativa Group PLC

Sativa Group welcomes new UK rules on cannabis-based medicine imports

Under new Home Office and Department of Health rules, medical wholesalers will be able to import larger quantities of cannabis-based products and hold supplies for future use

Sativa Group PLC -

Sativa Group PLC (NEX:SATI) said the UK government’s decision this week to allow faster access to prescribed cannabis-based medicines shows the country is “fast-developing as a significant medicinal cannabis market”.

From Monday 2 March, the Department of Health and Social Care and the Home Office said import restrictions have been lifted to help ensure people with medical prescriptions for cannabis-based do not have their treatment delayed or interrupted.

READ: Sativa welcomes new FSA guidelines on CBD

Licensed medical wholesalers will now be able to import larger quantities of cannabis-based products and hold supplies for future use by patients with prescriptions.

This followed changes in 2018 where specialist UK doctors were allowed to prescribe cannabis-based products for appropriate medicinal use.

Sativa, which last October became one of the few organisation that holds a Home Office controlled drug licence that allows it to cultivate, produce and supply cannabis for research purposes, said that it intends to “extend its participation” in the market.

Chief executive Henry Lees-Buckley said this week's government announcement “goes some way towards levelling the playing field and making cannabis-based remedies more affordable and accessible to all”.

“However, there is still a long way to go to bring the UK in parallel with other countries where the benefits of cannabis-based remedies have been accessible for many years and the UK's own medicinal cannabis industry remains very much fettered.”

Sativa's businesses include testing facility PhytoVista Laboratories, the emerging Goodbody Wellness retail franchise chain, and Goodbody Botanicals, a range of low-tetrahydrocannabinol (THC) and CBD wellness products.

Last week Goodbody Botanicals won a product listing agreement with WH Smith's travel business.

Quick facts: Sativa Group PLC

Price: - -

NEX:SATI
Market: NEX
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Sativa Group PLC named herein, including the promotion by the Company of Sativa Group PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Sativa Investments PLC acquires UK-based PhytoVista Laboratories

Geremy Thomas, chief executive of Sativa Investments PLC (NEX:SATI), tells Proactive's Andrew Scott they've agreed to buy PhytoVista Laboratories, a UK-based lab that tests cannabis oils and hemp products, for £435,000. The British medicinal cannabis investment vehicle will pay £235,000...

on 4/7/18

2 min read